Title : Loss of Long Noncoding RNA NXTAR in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance.

Pub. Date : 2022 Jan 1

PMID : 34740892






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Androgen receptor (AR) signaling continues to play a dominant role in all stages of prostate cancer (PC), including castration-resistant prostate cancers (CRPC) that have developed resistance to second-generation AR antagonists such as enzalutamide. enzalutamide androgen receptor Homo sapiens
2 Androgen receptor (AR) signaling continues to play a dominant role in all stages of prostate cancer (PC), including castration-resistant prostate cancers (CRPC) that have developed resistance to second-generation AR antagonists such as enzalutamide. enzalutamide androgen receptor Homo sapiens
3 Androgen receptor (AR) signaling continues to play a dominant role in all stages of prostate cancer (PC), including castration-resistant prostate cancers (CRPC) that have developed resistance to second-generation AR antagonists such as enzalutamide. enzalutamide androgen receptor Homo sapiens